Kwa, S., Lai, L., Gangadhara, S., Siddiqui, M., Pillai, V. B., Labranche, C., . . . Amara, R. R. (2014). CD40L-Adjuvanted DNA/Modified Vaccinia Virus Ankara Simian Immunodeficiency Virus SIV239 Vaccine Enhances SIV-Specific Humoral and Cellular Immunity and Improves Protection against a Heterologous SIVE660 Mucosal Challenge. American Society for Microbiology.
Citação norma ChicagoKwa, Suefen, et al. CD40L-Adjuvanted DNA/Modified Vaccinia Virus Ankara Simian Immunodeficiency Virus SIV239 Vaccine Enhances SIV-Specific Humoral and Cellular Immunity and Improves Protection against a Heterologous SIVE660 Mucosal Challenge. American Society for Microbiology, 2014.
Citação norma MLAKwa, Suefen, et al. CD40L-Adjuvanted DNA/Modified Vaccinia Virus Ankara Simian Immunodeficiency Virus SIV239 Vaccine Enhances SIV-Specific Humoral and Cellular Immunity and Improves Protection against a Heterologous SIVE660 Mucosal Challenge. American Society for Microbiology, 2014.